Welcome!

News Feed Item

Top Technologies in Health and Wellness

LONDON, March 10, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Top Technologies in Health and Wellness

This research service provides a list of key technology trends in health and wellness that are likely to have an impact in the year 2013 until 2017. The slides provide a brief snapshot of the technology, the key benefits or strengths, trends and initiatives, key stakeholders and their solutions, applications, enabling technologies, insights and recommendations as applicable for the identified list of technologies.

Research Scope and Index

Top Technology Trends:
Personalized Medicine
Targeted Drug Delivery
Regenerative Medicine
Biomarkers
Next-Generation Prebiotics
Nutrient Encapsulation
Nanoparticle-based Therapies
Biosensing
Next-Generation Sequencing

Recombinant Expression Systems

Technical Insights division of Frost & Sullivan evaluated technology trends in the Health and Wellness sector and has identified top technology trends that are likely to have an impact in the year 2013.
The slides provide information on the following lines on a best effort basis, as applicable to the technology under consideration.

They are as follows:
• Brief Snapshot of the Technology
• Recent Developments
• Key Stakeholders and their Solutions
• Future Scenario

Research Methodology

Primary Research
•Engineers
•CTOs/CEOs/CIOs
•Technical Architects
•Research Heads
•Strategic Decision Makers
•Technology Policy Heads

Secondary Research
•Technology Journals
•Periodicals
•Market Research Reports
•Technology Policy information Sites
•Internal Databases
•Thought Leader Briefings

Overview

Personalized medicine involves the study of human diseases at molecular level, pairing the advances in molecular diagnostics, along with genomics based drug development. Particular treatment design according to the individual's genome and epigenome is the goal.
As the aging population grows and seeks more services for disease screening, diagnosis and monitoring, the demand for novel life sciences tools increases.

Importance

•Personalized medicine (PM) aims to characterize disease at different levels and evolution stages to target specific genes or molecular pathways.
•Miniaturized, wireless, implantable sensors, are finding increased opportunities to more conveniently provide real-time information about a patient's condition.
•Omics-based technologies have revolutionized life sciences research and biomedical engineering, by generating huge amounts of information.
•Important efforts are being conducted toward becoming this information in valuable insights for clinical and biomedical routine tools for early diagnostics and prognostics.

Year of Impact

•Personalized medicine involves an evolving challenge from part of a broad spectrum of fields of research covering both sciences traditionally contributing to medicine and healthcare advances, such as genetics, biology, and pharmacology, and their -omics related fields, that is, proteomics, transcriptomics, metabonomics, and so on.
•More recently contributing sciences, such as bioinformatics, robotics, nanobiotechnology, mechatronics, and biomics, also play a critical role in the impact of personalized medicine in the human health.
•A solid convergence of these technologies is expected by 2016 for commercialization and 2018 for wide scale adoption.

Technical Background

Technology Overview
•Personalized medicine (PM) deeply digs inside the study of human diseases at molecular level, pairing the advances in molecular diagnostics, as well as, genomics based drug development. The aim of PM is to harmonize the relation between treatment and patient, taking into consideration the individual variations that lead to a specific behavior and drug response, could even involve the particular treatment design according to the individual genotype among other features.
•Toward this concept, coined terms as stratified medicine and integrated healthcare attempt to cover developments in genomics-based personalized medicines for different clusters, predisposition testing, preventive medicine, combination of diagnostics with therapeutics, and monitoring of therapy.
•A new vision attempting to avoid costly and prolonged trial and error approaches, while precluding treatment side effects, in conjunction with significant gain time, is being achieved.

Applications
•Personalized diagnostics and therapeutics
•Response drug evaluation and screening for new, more specific molecular entities
•Facing rare disease challenges for novel solutions
•Addressing autoimmune and inflammatory diseases therapies

Key Strengths
•Attrition rate, risk, cost and time reduction
•Use of virtual clinical trials and more caution experimental design for stratified groups
•Holistic view of human health
•New niches for molecular entities

Technology Roadmap (2000-2020)

1. Stratified Medicine
Applications
Gene expression/disease correlation
Multi-scale modeling
PoC diagnostics
LoC microdevices
Tools/Platforms
Pathways modeling/simulation and biomarkers development
Focus on cancer research
Issues
In silico, in vitro, in vivo models for experimental design and clinical trials

2. Personalized Theranostics
Applications
Single molecule biosensors
High-throughput glycomics
Systems biology/Modeling and simulation
Micro/nanotech for cancer/infectious diseases diagnostics
Tools/Platforms
Flexible assay platform (platform independence)
Multipanel biomarker assays
Issues
Omics technologies

3. Virtual Patients
Applications
Personalized medicine
Virtual populations for clinical trials
Disease prediction and risk management
Smart vaccination
Targeted tumor therapeutics
Tools/Platforms
Epigenome-based tech platforms
In silico early diagnostic tests
Pathway regulation therapeutics
Issues
Circulating customized microvesicle-based cancer testing

Technology Development and Adoption Footprint

North America
Pioneering in PM, the US possess one of the strongest R&D networks, counting with solid and well established public and private funding sources

Europe
The EU is remarkable promoting the advancement of PM approaches through its numerous FP7 programmes. In turn, national ecosystems are also emerging

APAC
Japan, India and Australia lead the development of PM, not only in a direct manner, but also promoting the development of enabling cutting-edge technologies

Industry Landscape

Academia
Marshfield Clinic, Wisconsin, US: Establishment of the Center for Medical Genetics, Personalized Medicine Research Center, Personalized Medicine Research Project (PMRP), Wisconsin Genomics Initiative (WGI). University of California San Francisco (UCSF), US: Collaboration line with Kaiser Permanente (an insurance company) to expand its existing data bank of clinical information to include genetic sequencing information. Launch of the Research Program on Genes, Environment and Health (RPGEH) initiative, and the Pharmacogenomics Research Network'(PGRN). University of Chicago, US: Launch of the 1200 Patients Project to pave the way for introducing the PM approach in the clinical routine. Mayo Clinic;, US: Creation of the Center for Individualized Medicine, with its Translational and Infrastructure programmes. Etc.

Research Labs
Indiana Center for Systems Biology and Personalized Medicine, Center for Integration of Medicine & Innovative Technology (CIMIT)-Massachusetts General Hospital (MGH), Integrated Biobank of Luxembourg (IBBL), Fraunhofer Institute for Systems and Innovation Research, Institut national de la santé et de la recherche médicale (Inserm), The Institute for Personalized Respiratory Medicine of the University of Illinois Hospital and Health Sciences System, Interuniversity Microelectronics Centre(IMEC), etc.

Corporates
Affymetrix, Cynvenio, DNA Genotek, Genia, Illumina, Life Technologies, Amgen, Astellas, BI, BMS, Eli Lilly, EMD Serono, Endo Health Solutions, GE, GSK, J&J, Merck, Millennium, Novartis, Pfizer, Atossa Genetics, Fluxion, Nodality, 23andMe, Cureline, Genophen, iSpecimen, N-of-One, Selventa, Kinemed, etc.

Government Agencies/Funding Bodies
Agencies financially supporting PM projects: The Biomedical Information Science and Technology Initiative (NIH/BISTI), National Institute of General Medical Sciences (NIH/NIGMS), Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS), Small Business Innovation Research (SBIR), Small Business Technology Transfer Program (STTR), European Commission (EU), European Research Council (ERC), European Science Foundation (ESF), European Association for Predictive, Preventive and Personalised Medicine (EPMA), European Organisation of Personalised Medicine (EPEMED), Asia-Pacific Economic Cooperation (APEC), which through their multiple framework programmes hold strong focus on PM envisioning 2020. VCs: Burrill & Company, Kleiner Perkins Caufield & Byers, Mohr Davidow, Pappas Ventures, Third Rock Ventures, LLC

Regulators/ Associations/Standardization Bodies
FDA and EMA have issued draft guidelines on registration and approval procedures regarding patient populations stratification to facilitate targeted therapy.

Table of Contents

Executive Summary 3
Personalized Medicine 6
Targeted Drug Delivery 16
Regenerative Medicine 26
Biomarkers 36
Next-Generation Prebiotics 46
Nutrient Encapsulation 51
Nanoparticle-based Therapies 56
Biosensing 61
Next-Generation Sequencing 66
Recombinant Expression Systems 72
The Frost & Sullivan Story 77

Read the full report:
Top Technologies in Health and Wellness
http://www.reportbuyer.com/countries/north_america/usa/top_technologies_health_wellness.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
As hybrid cloud becomes the de-facto standard mode of operation for most enterprises, new challenges arise on how to efficiently and economically share data across environments. In his session at 21st Cloud Expo, Dr. Allon Cohen, VP of Product at Elastifile, will explore new techniques and best practices that help enterprise IT benefit from the advantages of hybrid cloud environments by enabling data availability for both legacy enterprise and cloud-native mission critical applications. By rev...
In his session at 21st Cloud Expo, James Henry, Co-CEO/CTO of Calgary Scientific Inc., will introduce you to the challenges, solutions and benefits of training AI systems to solve visual problems with an emphasis on improving AIs with continuous training in the field. He will explore applications in several industries and discuss technologies that allow the deployment of advanced visualization solutions to the cloud.
Join IBM November 1 at 21st Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA, and learn how IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Cognitive analysis impacts today’s systems with unparalleled ability that were previously available only to manned, back-end operations. Thanks to cloud processing, IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Imagine a robot vacuum that becomes your personal assistant tha...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
Coca-Cola’s Google powered digital signage system lays the groundwork for a more valuable connection between Coke and its customers. Digital signs pair software with high-resolution displays so that a message can be changed instantly based on what the operator wants to communicate or sell. In their Day 3 Keynote at 21st Cloud Expo, Greg Chambers, Global Group Director, Digital Innovation, Coca-Cola, and Vidya Nagarajan, a Senior Product Manager at Google, will discuss how from store operations...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, will discuss how they bu...
Nordstrom is transforming the way that they do business and the cloud is the key to enabling speed and hyper personalized customer experiences. In his session at 21st Cloud Expo, Ken Schow, VP of Engineering at Nordstrom, will discuss some of the key learnings and common pitfalls of large enterprises moving to the cloud. This includes strategies around choosing a cloud provider(s), architecture, and lessons learned. In addition, he’ll go over some of the best practices for structured team migrat...
SYS-CON Events announced today that Datera will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Datera offers a radically new approach to data management, where innovative software makes data infrastructure invisible, elastic and able to perform at the highest level. It eliminates hardware lock-in and gives IT organizations the choice to source x86 server nodes, with business model option...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Infoblox delivers Actionable Network Intelligence to enterprise, government, and service provider customers around the world. They are the industry leader in DNS, DHCP, and IP address management, the category known as DDI. We empower thousands of organizations to control and secure their networks from the core-enabling them to increase efficiency and visibility, improve customer service, and meet compliance requirements.
Digital transformation is changing the face of business. The IDC predicts that enterprises will commit to a massive new scale of digital transformation, to stake out leadership positions in the "digital transformation economy." Accordingly, attendees at the upcoming Cloud Expo | @ThingsExpo at the Santa Clara Convention Center in Santa Clara, CA, Oct 31-Nov 2, will find fresh new content in a new track called Enterprise Cloud & Digital Transformation.
SYS-CON Events announced today that NetApp has been named “Bronze Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. NetApp is the data authority for hybrid cloud. NetApp provides a full range of hybrid cloud data services that simplify management of applications and data across cloud and on-premises environments to accelerate digital transformation. Together with their partners, NetApp emp...
SYS-CON Events announced today that N3N will exhibit at SYS-CON's @ThingsExpo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. N3N’s solutions increase the effectiveness of operations and control centers, increase the value of IoT investments, and facilitate real-time operational decision making. N3N enables operations teams with a four dimensional digital “big board” that consolidates real-time live video feeds alongside IoT sensor data a...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...